Lifestyle Modification: Evaluation of the Effects of Physical Activity and Low-Glycemic-Index Mediterranean Diet on Fibrosis Score
-
Published:2023-08-10
Issue:16
Volume:15
Page:3520
-
ISSN:2072-6643
-
Container-title:Nutrients
-
language:en
-
Short-container-title:Nutrients
Author:
Curci Ritanna1, Bianco Antonella1, Franco Isabella1ORCID, Bonfiglio Caterina1ORCID, Campanella Angelo1ORCID, Mirizzi Antonella2ORCID, Giannuzzi Vito3, Cozzolongo Raffaele3, Veronese Nicola4ORCID, Osella Alberto Ruben1ORCID
Affiliation:
1. Laboratory of Epidemiology and Statistics, National Institute of Gastroenterology—IRCCS “S. de Bellis”, Via Turi, 70013 Castellana Grotte, Italy 2. Via Fratelli Morea, 23, 70017 Putignano, Italy 3. Gastroenterology Unit, National Institute of Gastroenterology—IRCCS “S. de Bellis”, Via Turi, 70013 Castellana Grotte, Italy 4. Geriatric Unit, Department of Medicine, University of Palermo, 90100 Palermo, Italy
Abstract
Background: Non-Alcoholic Fatty Liver Disease (NAFLD) is one the most prevalent causes of chronic liver disease worldwide. In the absence of an approved drug treatment, lifestyle modification is the first intervention strategy. This study aimed to estimate the main effect of two different physical activity (PA) programs, and a Low-Glycemic-Index Mediterranean Diet (LGIMD), or their combined effect on liver fibrosis parameters in subjects with NAFLD. Methods: Subjects with moderate or severe NAFLD grade of severity (n = 144) were randomly assigned to six intervention arms for three months: LGIMD, PA programs, and their combination. Data were collected at baseline, 45 days, and 90 days. Transient elastography was performed to assess the outcome. Results: at 90 days, a statistically significant reduction in kPa was found among subjects following LGMID (−2.85, 95% CI −5.24, −0.45) and those following an LGIMD plus PA1 (−2.37, 95% CI −4.39, −0.35) and LGIMD plus Pa2 (−2.21, 95% CI −4.10, −0.32). The contrast between time 2 and time 1 of the LGIMD plus PA2 treatment showed a statistically significant increase, and vice versa: the contrast between time 3 and time 2 of the same treatment showed a statistically significant reduction. The PA1 and PA2 arms also showed reduced kPa, although the results did not reach statistical significance. Conclusions: The intervention arms, LGIMD, LGIMD+PA1, and LGIMD+PA2, reduced the fibrosis score.
Subject
Food Science,Nutrition and Dietetics
Reference51 articles.
1. Epidemiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis in Japan: A Focused Literature Review;Eguchi;JGH Open,2020 2. Non-Alcoholic Fatty Liver Disease, the Metabolic Syndrome and the Risk of Cardiovascular Disease: The Plot Thickens;Targher;Diabet. Med.,2007 3. Yabe, Y., Kim, T., Oh, S., Shida, T., Oshida, N., Hasegawa, N., Okada, K., Someya, N., Mizokami, Y., and Shoda, J. (2021). Relationships of Dietary Habits and Physical Activity Status with Non-Alcoholic Fatty Liver Disease Featuring Advanced Fibrosis. Int. J. Environ. Res. Public Health, 18. 4. The Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH;Loomba;Gastroenterology,2015 5. Le, M.H., Devaki, P., Ha, N.B., Jun, D.W., Te, H.S., Cheung, R.C., and Nguyen, M.H. (2017). Prevalence of Non-Alcoholic Fatty Liver Disease and Risk Factors for Advanced Fibrosis and Mortality in the United States. PLoS ONE, 12.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|